These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9431850

  • 1. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism.
    Sharifi AM, Schiffrin EL.
    J Hypertens; 1997 Dec; 15(12 Pt 1):1441-8. PubMed ID: 9431850
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
    Ammarguellat F, Larouche I, Schiffrin EL.
    Circulation; 2001 Jan 16; 103(2):319-24. PubMed ID: 11208696
    [Abstract] [Full Text] [Related]

  • 6. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
    Li JS, Larivière R, Schiffrin EL.
    Hypertension; 1994 Aug 16; 24(2):183-8. PubMed ID: 8039842
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
    Giulumian AD, Pollock DM, Clarke N, Fuchs LC.
    Am J Physiol; 1998 Jun 16; 274(6):R1613-8. PubMed ID: 9608015
    [Abstract] [Full Text] [Related]

  • 9. Cardiac microvasculature in DOCA-salt hypertensive rats : effect of endothelin ET(A) receptor antagonism.
    Larouche I, Schiffrin EL.
    Hypertension; 1999 Oct 16; 34(4 Pt 2):795-801. PubMed ID: 10523363
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, Morimoto S.
    Jpn J Pharmacol; 1996 Apr 16; 70(4):313-9. PubMed ID: 8774759
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats.
    Pollock DM, Allcock GH, Krishnan A, Dayton BD, Pollock JS.
    Am J Physiol Renal Physiol; 2000 Feb 16; 278(2):F279-86. PubMed ID: 10662732
    [Abstract] [Full Text] [Related]

  • 16. Selective antagonism of endothelin ET(A) or ET(B) receptor in renal hemodynamics and function of deoxycorticosterone acetate-salt-induced hypertensive rats.
    Matsumura Y, Taira S, Kitano R, Hashimoto N, Kuro T.
    Biol Pharm Bull; 1999 Aug 16; 22(8):858-62. PubMed ID: 10480326
    [Abstract] [Full Text] [Related]

  • 17. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
    Fujita K, Matsumura Y, Kita S, Miyazaki Y, Hisaki K, Takaoka M, Morimoto S.
    Br J Pharmacol; 1995 Mar 16; 114(5):925-30. PubMed ID: 7780646
    [Abstract] [Full Text] [Related]

  • 18. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
    Allcock GH, Venema RC, Pollock DM.
    Am J Physiol; 1998 Jul 16; 275(1):R245-52. PubMed ID: 9688985
    [Abstract] [Full Text] [Related]

  • 19. Microvascular responses to endothelin in deoxycorticosterone acetate-salt hypertensive rats.
    Zhao H, Joshua IG, Porter JP.
    Am J Hypertens; 2000 Jul 16; 13(7):819-26. PubMed ID: 10933575
    [Abstract] [Full Text] [Related]

  • 20. Effect of magnesium on mRNA expression and production of endothelin-1 in DOCA-salt hypertensive rats.
    Berthon N, Laurant P, Fellmann D, Berthelot A.
    J Cardiovasc Pharmacol; 2003 Jul 16; 42(1):24-31. PubMed ID: 12827022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.